Related Experiment Videos
Renal osteodystrophy--pathophysiological aspects
L Babić1, N Curić, I Cvetinović
1Institute of Pathophysiology, Medical faculty, Novi Sad.
Medicinski Pregled
|January 1, 1993
Summary
All dialysis patients have bone metabolism disturbances. The most common is hyperparathyroid bone disease, while mixed uremic osteodistrophy is less frequent, indicating a need for monitoring bone health in renal patients.
Area of Science:
- Nephrology
- Endocrinology
- Bone Metabolism
Background:
- Chronic kidney disease (CKD) significantly impacts bone health.
- Dialysis patients frequently develop renal osteodistrophy (ROD).
- Understanding ROD pathogenesis is crucial for patient management.
Purpose of the Study:
- To assess bone metabolism in patients undergoing chronic maintenance dialysis.
- To identify the primary mechanisms driving renal osteodistrophy.
- To correlate biochemical markers with scintigraphic findings.
Main Methods:
- Biochemical analysis of bone metabolism regulators.
- Measurement of bone metabolism parameters.
- Skeletal scintigraphy to evaluate metabolic bone activity.
Main Results:
- All evaluated dialysis patients exhibited disturbances in skeletal homeostasis.
- Hyperparathyroid bone disease was the predominant condition observed.
- Mixed uremic osteodistrophy (hyperparathyroidism and vitamin D deficiency) occurred in 6% of patients.
- Low turnover bone disease (osteomalacia or adynamic bone disease) was also identified.
Conclusions:
- Simultaneous assessment of biochemical factors and scintigraphy reveals skeletal homeostasis changes.
- Early detection of these changes can prevent severe bone complications.
- Adequate treatment strategies can be implemented based on identified disturbances.